Gyre Therapeutics (GYRE) Shares Issued (2016 - 2025)
Historic Shares Issued for Gyre Therapeutics (GYRE) over the last 13 years, with Q3 2025 value amounting to $1.3 million.
- Gyre Therapeutics' Shares Issued rose 24224.6% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 9237.06%. This contributed to the annual value of $1.9 million for FY2024, which is 2400.0% down from last year.
- Per Gyre Therapeutics' latest filing, its Shares Issued stood at $1.3 million for Q3 2025, which was up 24224.6% from $1.0 million recorded in Q2 2025.
- Over the past 5 years, Gyre Therapeutics' Shares Issued peaked at $49.3 million during Q1 2021, and registered a low of $275000.0 during Q2 2024.
- Over the past 3 years, Gyre Therapeutics' median Shares Issued value was $807000.0 (recorded in 2024), while the average stood at $6.8 million.
- Examining YoY changes over the last 5 years, Gyre Therapeutics' Shares Issued showed a top increase of 27527.27% in 2025 and a maximum decrease of 4528.88% in 2025.
- Quarter analysis of 3 years shows Gyre Therapeutics' Shares Issued stood at $49.3 million in 2021, then crashed by 98.8% to $593000.0 in 2024, then soared by 115.85% to $1.3 million in 2025.
- Its Shares Issued was $1.3 million in Q3 2025, compared to $1.0 million in Q2 2025 and $956000.0 in Q1 2025.